Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
I-Mab to Hold Investor Call to Report Latest Phase 2 Clinical Data of its Differentiated CD73 Antibody Uliledlimab 2022-05-19 20:00
Berry Oncology Launches an Innovative Self-Iterative "HIFI" System 2022-05-19 09:00
FSP, the Top Brand of Power Supply in Five Application Fields 2022-05-19 08:30
PostEra spearheads AI-driven drug discovery collaboration to develop antiviral therapeutics with initial $68M in NIH funding 2022-05-19 04:56
Ascentage Pharma Announces Preclinical Data Demonstrating Olverembatinib's Therapeutic Potential in Treating COVID-19 Published in EMBO Molecular Medicine 2022-05-18 22:06
OriCiro Genomics expand into Boston, Open new office in North America 2022-05-18 22:00
BioVaxys Confirms First Clinical Site and Principal Investigators for Ovarian Cancer Vaccine Trial and Enters into Second Tumor Cell Supply Agreement 2022-05-18 20:00
DelSiTech and Anticancer Bioscience Announce a Collaboration Agreement for the Development of Long-acting Therapies in Oncology 2022-05-18 16:00
Antengene Announces XPOVIO® Treatment Regimens Included for the First Time in the Guidelines for the Diagnosis and Management of Multiple Myeloma in China 2022-05-18 15:01
SIMCERE PHARMA (HK.2096) Novel Inhibitor of COVID-19 3CLpro SIM0417 Received a Second Clinical Trial Approval in China 2022-05-18 11:56
Sinclair Pharma Partners with Vanguard Aesthetics to Launch Silhouette Soft in Malaysia 2022-05-18 09:01
Vela Diagnostics Launches Multiplex PCR-Based Test for Detecting UTI Pathogens and Antimicrobial Resistance Genes 2022-05-17 22:00
KAZIA MARKS DIPG AWARENESS DAY; NEW PRECLINICAL DATA IN DIPG TO BE PRESENTED AT ISPNO CONFERENCE 2022-05-17 20:00
P&G Health dons the Purple Ribbon to commemorate Neuropathy Awareness Week 2022-05-17 19:24
ASEAN accepts mutually recognized COVID-19 vaccination certificates 2022-05-17 19:14
New therapeutic option to reduce risk of cardiovascular deaths and repeated hospitalizations among adult heart failure patients approved in Singapore 2022-05-17 16:32
ABL AND ODIMMA THERAPEUTICS JOIN FORCES IN PERSONALIZED CANCER IMMUNOTHERAPY 2022-05-17 15:00
CStone announces final PFS analysis of a registrational study of sugemalimab in patients with stage III NSCLC further demonstrates its robust efficacy and significant clinical benefits shown in interim analysis 2022-05-17 08:02
LifeOmic Applauded by Frost & Sullivan for Enabling More Cost-efficient, Targeted Holistic Precision Health with Its Interoperable Precision Health Solutions 2022-05-16 22:00
Ascletis (1672.HK) Included in MSCI China Small Cap Index 2022-05-16 20:17
1 248 249 250 251 252 892